✦ LIBER ✦

Hepatic artery infusion of 5-fluorouracil and mitomycin C in cholangiocarcinoma and gallbladder carcinoma

✍ Scribed by Gregory W. Smith; R. M. Bukowski; James S. Hewlett; Carl W. Groppe

Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 367 KB
Volume: 54
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19841015)54:8<1513::aid-cncr2820540806>3.0.co;2-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intrahepatic arterial infusion of combin

Intrahepatic arterial infusion of combination of mitomycin-C and 5-fluorouracil in treatment of primary and metastatic liver carcinoma

✍ Dr. N. C. Misra; M. S. D. Jaiswal; R. V. Singh; B. Das 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB 👁 2 views

improvement in drug response and reduction of toxicity were observed after continuous intrahepatic arterial infusion of mytomycin-C (MMC) and 5-fluorouracil (5-FU) in 15 of 26 patients with primary or metastatic carcinoma of the liver. Serum bilirubin values of 10 mg/100 ml absence of ascites, extre

Disposition of 5-fluorouracil during chr

Disposition of 5-fluorouracil during chronic hepatic arterial infusion to patients with carcinoma in the liver and effect on circulating platelets

✍ Daniel S. Sitar; John R. Ruedy; Douglas H. Shaw Jr.; Andrew W. Maksymiuk; Michae 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB 👁 1 views

## Abstract 5‐Fluorouracil was administered by continuous hepatic intra‐arterial infusion to eight patients with the diagnosis of cancer of the gastrointestinal tract and hepatic metastases. Its elimination characteristics were investigated to see if they correlated with therapeutic effect or reduc

5-fluorouracil, doxorubicin, and mitomyc

5-fluorouracil, doxorubicin, and mitomycin-C in the treatment of adenocarcinoma and large cell carcinoma of the lung

✍ Michael T. Shaw; Melinda K. Shaw 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB 👁 2 views

A phase II trial of 5-fluorouracil, doxo

A phase II trial of 5-fluorouracil, doxorubicin, mitomycin C, and leucovorin in advanced gastric carcinoma

✍ Susan G. Arbuck; Yusuf Silk Md; Harold O. Douglass Jr.; Hector Nava; Youcef M. R 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB 👁 2 views

To determine the feasibility and toxicity of combining leucovorin (CF) with a 5fluorouracil(5-FU) combination chemotherapy regimen currently accepted by many as standard treatment for gastric cancer, CF (500 mg/m') was administered in combination with the Georgetown S-FU, doxorubicin, and mitomycin

Phase II trial of 5-fluorouracil, adriam

Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinoma

✍ R. M. Bukowski; L. P. Schacter; C. W. Groppe; J. S. Hewlett; J. K. Weick; R. B. 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 2 views

Results of pharmacokinetic modulating ch

Results of pharmacokinetic modulating chemotherapy in combination with hepatic arterial 5-fluorouracil infusion and oral UFT after resection of hepatic colorectal metastases

✍ Masato Kusunoki; Hidenori Yanagi; Masafumi Noda; Reigetsu Yoshikawa; Takehira Ya 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## BACKGROUND. Pharmacokinetic modulating chemotherapy (PMC) is a new therapeutic concept in combination with continuous 5-fluorouracil (5-FU) infusion and UFT. UFT enhanced plasma 5-FU concentration and antitumor effects during 5-FU infusion. The authors report on their experiences with arterial